Castleview Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Buy |
828
+78
| +10% | +$60.8K | 0.41% | 55 |
|
|
2025
Q1 | $619K | Buy |
750
+53
| +8% | +$43.8K | 0.42% | 62 |
|
|
2024
Q4 | $542K | Buy |
697
+301
| +76% | +$234K | 0.29% | 84 |
|
|
2024
Q3 | $351K | Buy |
396
+123
| +45% | +$109K | 0.2% | 121 |
|
|
2024
Q2 | $247K | Sell |
273
-107
| -28% | -$96.9K | 0.14% | 145 |
|
|
2024
Q1 | $296K | Hold |
380
| – | – | 0.17% | 137 |
|
|
2023
Q4 | $222K | Buy |
380
+192
| +102% | +$112K | 0.16% | 130 |
|
|
2023
Q3 | $101K | Buy |
188
+4
| +2% | +$2.15K | 0.09% | 177 |
|
|
2023
Q2 | $86.3K | Hold |
184
| – | – | 0.08% | 196 |
|
|
2023
Q1 | $63.2K | Sell |
184
-89
| -33% | -$30.6K | 0.06% | 239 |
|
|
2022
Q4 | $99.9K | Hold |
273
| – | – | 0.1% | 161 |
|
|
2022
Q3 | $88K | Sell |
273
-576
| -68% | -$186K | 0.08% | 180 |
|
|
2022
Q2 | $39.7K | Buy |
849
+649
| +325% | +$30.4K | 0.03% | 331 |
|
|
2022
Q1 | $57K | Buy |
+200
| New | +$57K | 0.04% | 331 |
|
|
2021
Q2 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 862 |
|